Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...
Objective To 1) describe the characteristics and outcomes over time of PICU patients with severe sepsis within the dedicated U.S. children's hospitals, 2) identify patient subgroups at risk for ...
Objective To determine whether patients with severe sepsis or septic shock could benefit from a strict and early goal-directed therapy (EGDT) protocol recommended by Surviving Sepsis Campaign (SSC) ...
In a typical year, at least 1.7 million adults in America develop sepsis, a life-threatening response to infection. About 30% of severe sepsis patients don’t survive, and up to 50% of survivors ...
Sepsis is a life threatening illness that develops when an existing infection triggers an extreme immune system response in your body. When you experience an infection, your immune system releases ...
aaaht.scot.nhs.uk Background The Surviving Sepsis Campaign (SSC) promotes a bundle approach to the care of septic patients to improve outcome. Some have questioned the capability of delivering the ...